Trademark: EnfiniT platform for CAR-T 2240890
Word
EnfiniT platform for CAR-T
ID
2240890
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
14 September 2021
Registration Date
14 September 2021
Cancellation Date
02 March 2023
Owner(s)
Service
Griffith Hack
Goods and Services:
Class 1:
Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions.
Biological and chemical products for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions.
Class 5:
Pharmaceutical products; biological and pharmaceutical preparations; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic solutions, namely, antigen, antibodies, T-cells; biological materials, preparations, reagents for medical products; antigens, antibodies, cells for therapeutic use.
Pharmaceutical products; biological and pharmaceutical preparations; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic solutions, namely, antigen, antibodies, T-cells; biological materials, preparations, reagents for medical products; antigens, antibodies, cells for therapeutic use.
Class 40:
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacturing antigens, antibodies, T-cells.
Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; manufacturing antigens, antibodies, T-cells.
Class 42:
Scientific research services for medical purposes; identifying, screening and developing antigens; scientific and technological services; scientific laboratory services; providing scientific and medical information on immunotherapy; providing services for identifying, analyzng, authenticating, purifying and developing biological material from a genomic platform; epigenetic antigen screening and identification services for therapeutic research purposes; genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; services of computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; services of computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses.
Scientific research services for medical purposes; identifying, screening and developing antigens; scientific and technological services; scientific laboratory services; providing scientific and medical information on immunotherapy; providing services for identifying, analyzng, authenticating, purifying and developing biological material from a genomic platform; epigenetic antigen screening and identification services for therapeutic research purposes; genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; services of computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; services of computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses.